ইউরোপীয় ইউনিয়ন -
আইসল্যান্ডীয় -
EMA (European Medicines Agency)
maviret
abbvie deutschland gmbh co. kg - glecaprevir, pibrentasvir - lifrarbólga c, langvinn - veirueyðandi lyf til almennrar notkunar - maviret is indicated for the treatment of chronic hepatitis c virus (hcv) infection in adults and children aged 3 years and older. maviret coated granules is indicated for the treatment of chronic hepatitis c virus (hcv) infection in children 3 years and older.
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
simdax innrennslisþykkni, lausn 2,5 mg/ml
orion corporation - levosimendanum inn - innrennslisþykkni, lausn - 2,5 mg/ml
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
kairasec tafla 8 mg
medical valley invest ab - candesartanum cílexetíl - tafla - 8 mg
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
kairasec tafla 16 mg
medical valley invest ab - candesartanum cílexetíl - tafla - 16 mg
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
kairasec tafla 32 mg
medical valley invest ab - candesartanum cílexetíl - tafla - 32 mg
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
tegretol mixtúra, dreifa 20 mg/ml
novartis healthcare a/s - carbamazepinum inn - mixtúra, dreifa - 20 mg/ml
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
tegretol retard forðatafla 200 mg
novartis healthcare a/s - carbamazepinum inn - forðatafla - 200 mg
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
tegretol retard forðatafla 400 mg
novartis healthcare a/s - carbamazepinum inn - forðatafla - 400 mg
ইউরোপীয় ইউনিয়ন -
আইসল্যান্ডীয় -
EMA (European Medicines Agency)
eurartesim
alfasigma s.p.a. - piperaquine tetraphosphate, artenimol - malaría - krabbamein - eurartesim er ætlað til meðhöndlunar á ósamþykktum malaríumplasma í fósturvísi hjá fullorðnum, börnum og ungbörnum 6 mánaða og eldri og vega 5 kg eða meira. Íhuga ætti að opinbera leiðsögn á réttri notkun malaríulyf lyfjum.
ইউরোপীয় ইউনিয়ন -
আইসল্যান্ডীয় -
EMA (European Medicines Agency)
onduarp
boehringer ingelheim international gmbh - telmisartan - háþrýstingur - hjarta og æðakerfi - meðferð háþrýstingi í fullorðnir:bæta á therapyonduarp er ætlað í fullorðnir sem blóðþrýstingur er ekki nægilega stjórn á meðferð. skipti therapyadult sjúklingar fá efnaskipti og meðferð frá sér töflur getur stað fá töflur onduarp inniheldur sama hluti skömmtum.